Document:

EX 10.2 - WarranttoPurchaseCommonStock

EXHIBIT 10.2

CCA INDUSTRIES, INC.
WARRANT TO PURCHASE COMMON STOCK
VOID AFTER 5:00 P.M. (UNITED STATES EASTERN TIME)
ON SEPTEMBER 5, 2019, AS PROVIDED HEREIN.
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND OTHER APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITY IS THEN IN EFFECT, OR SUCH REGISTRATION UNDER THE SECURITIES ACT AND OTHER APPLICABLE SECURITIES LAWS IS NOT REQUIRED DUE TO AVAILABLE EXEMPTIONS FROM SUCH REGISTRATION. 
Issuance Date: September 5, 2014
FOR VALUE RECEIVED, CCA Industries, Inc., a Delaware corporation (“Company”), hereby agrees to sell to Capital Preservation Solutions, LLC, a Delaware limited liability company, or its registered assigns (the “Holder”), upon the terms and on the conditions of this warrant (this “Warrant”), the number of fully paid and non-assessable shares of Common Stock representing an aggregate amount of Common Stock (the “Warrant Stock”), when added to  all shares of Common Stock previously issued upon exercise of this Warrant, that does not exceed twenty-four (24%) of the amount equal to (a) the Company’s issued and outstanding shares of Common Stock and Class A Common Stock as of each date this Warrant is exercised in accordance with the terms set forth herein, less (b) in each case, the aggregate amount of shares of Common Stock (if any) issued upon exercise of this Warrant (the amount of clause (a) and (b) shall be referred to as the “Outstanding Capital Stock Amount”) at a purchase price of $3.17 per share (such amount, subject to the adjustments set forth herein, the “Warrant Price”).  For the avoidance of doubt, at each exercise of this Warrant (each an “Exercise Event”), all shares of Common Stock that were issued upon exercise of this Warrant prior to such Exercise Event shall be included in the calculation to determine whether the Holder will, following such Exercise Event, own more than twenty-four (24%) of the Outstanding Capital Stock Amount.  The number of shares of Warrant Stock to be so issued and the Warrant Price are subject to adjustment in certain events as hereinafter set forth.  The term “Common Stock” shall mean, when used herein,  the common stock of the Company, par value $.01 per share, and any capital stock into which such common stock shall have been converted, exchanged or reclassified following the date hereof.
1.Term of Warrant.  Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part and from time to time, during the term commencing on the date hereof and ending at 5:00 p.m. (United States Eastern Time) on September 5, 2019 (subject to extension as provided below, the “Exercise Period”); provided, however, that in the event that the expiration date of this Warrant shall fall on a Saturday, Sunday or United States federally recognized 

 

holiday, the expiration date for this Warrant shall be extended to 5:00 p.m. (United States Eastern Time) on the first business day following such Saturday, Sunday or recognized holiday.
2.    Exercise of Warrant.  
(a)    This Warrant may be exercised by the Holder, in whole or in part, at any time and from time to time during the Exercise Period by: 
(i)    completing the exercise form attached hereto (the “Exercise Notice”); 
(ii)    surrendering this Warrant to the Company at the address set forth in Section 9; and 
(iii)    paying to the Company an amount equal to (A) the number of shares of Warrant Stock in respect of which this Warrant is being exercised pursuant to this Section 2 multiplied by (B) the Warrant Price in effect as of the date on which this Warrant is exercised (the “Aggregate Exercise Price”) in accordance with Section 2(b).
(b)    Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed in the Exercise Notice, by the following methods: 
(i)    by delivery to the Company of a certified or official bank check payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company, in the amount of such Aggregate Exercise Price;
(ii)    by instructing the Company to withhold or cancel a number of shares of Warrant Stock then issuable upon exercise of this Warrant with an aggregate Fair Market Value (as defined in Section 2(c) below) as of the date on which this Warrant is exercised pursuant to this Section 2 equal to such Aggregate Exercise Price; or 
(iii)    any combination of (i) or (ii).
(c)    When used herein, the term “Fair Market Value” shall mean, as of any particular date:  (a) the volume weighted average of the closing sales prices of the Common Stock for such day on all domestic securities exchanges on which the Common Stock may at the time be listed; (b) if there have been no sales of the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock on all such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a domestic securities exchange, the closing sales price of the Common Stock as quoted on the Financial Industry Regulatory Authority OTC Bulletin Board electronic inter-dealer quotation system (the “OTC Bulletin Board”), the OTC Markets Group Inc. electronic inter-dealer quotation system, including OTCQX, OTCQB or OTC Pink (the “Pink OTC Markets”) or similar quotation system or association for such day; or (d) if there have been no sales of the Common Stock on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association on such day, the average of the highest bid and lowest asked prices for the Common Stock quoted on the OTC Bulletin Board, 

2

the Pink OTC Markets or similar quotation system or association at the end of such day; in each case, averaged over twenty (20) consecutive Trading Days ending on the Trading Day immediately prior to the day as of which “Fair Market Value” is being determined; provided, that if the Common Stock is listed on any domestic securities exchange, the term “Trading Day” as used in this sentence means Trading Days on which such exchange is open for trading. If at any time the Common Stock is not listed on any domestic securities exchange or quoted on the OTC Bulletin Board, the Pink OTC Markets or similar quotation system or association, the “Fair Market Value” of the Common Stock shall be the fair market value per share as determined by the Board of Directors of the Company.
(d)    No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.  The Company shall pay cash in lieu of fractional shares based upon the Fair Market Value of such fractional shares of Common Stock at the date of exercise of this Warrant. 
(e)    In the event of any exercise of the rights represented by this Warrant, the Warrant Stock so purchased shall be registered in the name of the Holder within a reasonable time after such rights shall have been so exercised.  The Person in whose name the Warrant Stock is registered upon exercise of the rights represented by this Warrant shall for all purposes be deemed to have become the holder of record of such Warrant Stock immediately prior to the close of business on the date on which the Warrant was surrendered and payment of the Aggregate Exercise Price and any applicable taxes was made, irrespective of the date of registration of the Warrant Stock, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such Person shall be deemed to have become the holder of such Warrant Stock at the opening of business on the next succeeding date on which the stock transfer books are open.  The Company shall pay any and all documentary stamp or similar issue or transfer taxes payable in respect of the issue or delivery of shares of Common Stock on exercise of this Warrant.  When used herein, the term “Person” shall mean any individual, sole proprietorship, joint venture, partnership, company, corporation, association, cooperation, trust, estate, governmental authority, or any other entity of any nature whatsoever.
3.    Restrictions on Disposition of Warrant and Warrant Stock.
(a)    The Holder hereby acknowledges that (i) this Warrant and any Warrant Stock that may be acquired upon exercise of this Warrant pursuant hereto are, as of the date hereof, not registered: (A) under the Securities Act on the ground that the issuance of this Warrant is exempt from registration under Section 4(a)(2) of the Securities Act as not involving any public offering or (B) under any applicable state securities laws, and (ii) the Company’s reliance on the Section 4(a)(2) exemption of the Securities Act and under applicable state securities laws is predicated in part on the representations hereby made to the Company by the Holder.  The Holder represents and warrants that: 
(iv)    the Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act;

3

(v)    the Holder is acquiring this Warrant and the Warrant Stock to be issued upon exercise hereof for investment for its own account and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Stock, except pursuant to sales registered or exempted under the Securities Act;
(vi)    the Holder does not presently have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or effect any distribution of any of this Warrant or the Warrant Stock to or through any Person; 
(vii)    the Holder understands and acknowledges that this Warrant and the Warrant Stock to be issued upon exercise hereof are “restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that, under such laws and applicable regulations, such securities may be resold without registration under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule 144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act;
(viii)    the Holder is not a registered broker-dealer under Section 15 of the Securities Exchange Act of 1934, as amended, or an entity engaged in a business that would require it to be so registered as a broker-dealer;
(ix)    the Holder, either alone or together with its representatives (if any), has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in this Warrant and the Warrant Stock, and has so evaluated the merits and risks of such investment; and
(x)    the Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant and the Warrant Stock. The Holder has had an opportunity to ask questions of, and receive answers from, the Company’s officers, employees, agents and representatives regarding the terms and conditions of the offering of the Warrant and the business, properties, prospects and financial condition of the Company.
(b)    If, at the time of issuance of Warrant Stock upon exercise of this Warrant, no registration statement is in effect with respect to such shares under applicable provisions of the Securities Act and other applicable securities laws, Holder hereby agrees that Holder will not sell, transfer, offer, pledge, hypothecate or otherwise dispose of all or any part of the Warrant Stock unless and until Holder shall first have given notice to the Company describing such sale, transfer, offer, pledge, hypothecation or other disposition and there shall be available exemptions from such registration requirements that exist.  Should there be any reasonable uncertainty or good faith disagreement between the Company and the Holder as to the availability of such exemptions, then the Holder shall be required to deliver to the Company (i) an opinion satisfactory to the Company rendered by counsel selected by the Holder to the effect that such offer, sale, transfer, pledge, hypothecation or other disposition is in compliance with an available exemption under the Securities Act and other applicable securities laws, or (ii) an interpretative letter from the Securities and 

4

Exchange Commission to the effect that no enforcement action will be recommended if the proposed offer, sale, transfer, pledge  hypothecation or other disposition is made without registration under the Securities Act.  If, at the time of issuance of Warrant Stock upon exercise of this Warrant, no registration statement is in effect with respect to such shares under applicable provisions of the Securities Act and other applicable securities laws, the Warrant Stock issued upon exercise of this Warrant shall bear a legend reading substantially as follows: 
“THESE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND OTHER APPLICABLE STATE SECURITIES LAWS WITH RESPECT TO SUCH SECURITY IS THEN IN EFFECT, OR SUCH REGISTRATION UNDER THE SECURITIES ACT AND OTHER APPLICABLE SECURITIES LAWS IS NOT REQUIRED DUE TO AVAILABLE EXEMPTIONS FROM SUCH REGISTRATION.”
4.    Reservation of Shares; Certain Representations and Warranties; Certain Covenants.  The Company hereby agrees, represents and warrants that at all times there shall be reserved for issuance upon the exercise of this Warrant such number of shares of its Common Stock (or other securities subject to this Warrant from time to time) as shall be required for issuance upon exercise of this Warrant.  The Company further agrees that all shares of Warrant Stock represented by this Warrant have been duly authorized and will, upon issuance and against payment of the Aggregate Exercise Price, be validly issued, fully paid and non-assessable.  The Company represents and warrants that (a) its execution and delivery of this Warrant has been authorized by all necessary and appropriate corporate action under its organizational documents and any applicable agreements and in conformity with applicable law and the rules of the NYSE MKT and that this Warrant has been executed by an authorized representative of the Company; provided, however, that until such time as the Company has advised the Holder of the listing of the Warrant Stock on the NYSE MKT, such Warrant Stock has not been listed on the NYSE MKT; and (b) this Warrant represents a valid, legal and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that such enforceability is limited by bankruptcy, receivership, moratorium, conservatorship, or reorganization laws or other laws of general application affecting the rights of creditors generally or by general principles of equity.  The Company shall not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant.  The Company shall have (i) within three business days after the date hereof (as such date may be extended by the Holder in its sole discretion), filed a listing application with the NYSE MKT with respect to the listing of the Warrant Stock on the NYSE MKT, and (ii) within 30 days after the date hereof (as such date may be extended by the Holder in its sole discretion), delivered to the Holder evidence of approval by the NYSE MKT for listing of the Warrant Stock on the NYSE MKT.  
5.    Capital Adjustments.  This Warrant is subject to the following further provisions: 

5

(a)    Adjustment to Warrant Price Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall, at any time or from time to time from the date hereof until the end of the Exercise Period, (i) pay a dividend or make any other distribution upon the Common Stock or any other capital stock of the Company payable in shares of Common Stock or in Options or Convertible Securities, or (ii) subdivide (by any stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Warrant Price in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately reduced. If the Company at any time from the date hereof and until the end of the Exercise Period combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Warrant Price in effect immediately prior to such combination shall be proportionately increased.  Any adjustment under this Section 5(a)) shall become effective at the close of business on the date the dividend, subdivision or combination becomes effective.  When used herein, the term “Options” shall mean any warrants or other rights or options to subscribe for or purchase Common Stock or Convertible Securities, and the term “Convertible Securities” shall mean any securities (directly or indirectly) convertible into or exchangeable for Common Stock, but excluding Options.
(b)    Adjustment to Warrant Price Upon Reorganization, Reclassification, Consolidation or Merger. If, at any time or from time to time from the date hereof until the end of the Exercise Period, any (i) capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend, subdivision, or combination addressed by Section 5(a)), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of the Company's assets to another Person or (v) other similar transaction (other than any such transaction covered by Section 5(a)), in each case which entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger, sale or other such transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of shares of Warrant Stock then exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such reorganization, reclassification, consolidation, merger, sale or other such  transaction if the Holder had exercised this Warrant in full immediately prior to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction and acquired the applicable number of shares of Warrant Stock then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance satisfactory to the Company and the Holder) shall be made with respect to the Holder's rights under this Warrant to insure that the provisions of this Section 5 shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Warrant. The provisions of this Section 5(b) shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales or similar transactions that occur any time from the date hereof until the end of the Exercise Period. At any time from the date hereof until the end of the Exercise Period, the Company shall not effect any such reorganization, reclassification, consolidation, merger, sale or similar transaction 

6

unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting from such reorganization, reclassification, consolidation, merger, sale or similar transaction, shall assume, by written instrument substantially similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant. Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by the provisions of this Section 5(b), the Holder shall have the right, until the end of the Exercise Period, to elect prior to the consummation of such event or transaction, to give effect to the exercise rights contained in Section 1 instead of giving effect to the provisions contained in this Section 5(b) with respect to this Warrant. 
(c)    No Other Adjustments. Except for those adjustments provided for in Sections 5(a) and 5(b), there shall be no other adjustment to the Warrant Price or the number of shares of Warrant Stock issuable upon exercise of this Warrant, including, without limitation, with respect to any issuance or sale by the Company after the date of this Warrant of: (i) shares of Common Stock issued upon the exercise of this Warrant; (ii) shares of Common Stock issued directly or upon the exercise or conversion of Options or Convertible Securities to directors, officers, employees, or consultants of the Company in connection with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company, as applicable, in each case, which are authorized by the Board of Directors of the Company and are issued pursuant to a bonus plan, stock option or equity–based plan or other similar policy or program of the Company (including, without limitation, the Company’s 2005 Amended and Restated Stock Option Plan); (iii) shares of Common Stock issued upon the exercise or conversion of Options and Convertible Securities issued prior to the date of this Warrant, provided that such securities are not amended (except with respect to amendments to reflect adjustments for stock splits, stock combinations, stock dividends and recapitalizations) after the date hereof to increase the number of shares of Common Stock issuable thereunder or to lower the exercise or conversion price thereof; and (iv) shares of Common Stock, Options, Convertible Securities or other securities issued following the date of this Warrant to financial institutions, strategic or institutional investors, or other Persons in connection with credit arrangements, financings or similar transactions which are approved by the Board of Directors of the Company. 
(d)    Certificate as to Adjustment. 
(i)    As promptly as reasonably practicable following any adjustment of the Warrant Price, but in any event not later than 10 business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof.
(ii)    As promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later than 10 business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying the Warrant Price then in effect and the number of shares of Warrant Stock or the amount, if any, of other shares of stock, securities or assets then issuable upon exercise of the Warrant.
6.    Notice to Holder. 

7

(a)    Notice of Record Date.  In the event:
(i)    that the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon exercise of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to vote at a meeting (or by written consent), to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities, or to receive any other security; or
(ii)    of any capital reorganization of the Company, any reclassification of the Common Stock of the Company, any consolidation or merger of the Company with or into another Person, or sale of all or substantially all of the Company's assets to another Person; or 
(iii)    of the voluntary or involuntary dissolution, liquidation or winding-up of the Company;
then, and in each such case, the Company shall send or cause to be sent to the Holder at least 10 days prior to the applicable record date or the applicable expected effective date, as the case may be, for the event, a written notice specifying, as the case may be, (A) the record date for such dividend, distribution, meeting or consent or other right or action, and a description of such dividend, distribution or other right or action to be taken at such meeting or by written consent, or (B) the effective date on which such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up is proposed to take place, and the date, if any is to be fixed, as of which the books of the Company shall close or a record shall be taken with respect to which the holders of record of Common Stock (or such other capital stock or securities at the time issuable upon exercise of the Warrant) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Warrant and the Warrant Stock.
7.    Loss, Theft, Destruction or Mutilation.  Upon receipt by the Company of evidence satisfactory to it of the ownership and the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, of indemnity reasonably satisfactory to the Company and, in the case of mutilation, upon surrender and cancellation thereof, the Company will execute and deliver a new Warrant of like tenor dated the date hereof.
8.    Warrant Holder not a Stockholder.  Without limiting rights of the Holder in respect of any shares of stock of the Company or other securities owned by the Holder, the Holder of this Warrant shall not be entitled by reason of holding this Warrant to any rights whatsoever as a stockholder of the Company.
9.    Notices.  All notices, consents, waivers, and other communications required or permitted by this Warrant shall be in writing and shall be deemed given to a party when (i) delivered to the appropriate address by hand or by nationally recognized courier service (costs prepaid); (ii) sent by facsimile with confirmation of transmission by the transmitting equipment; or (iii) received or rejected by the addressee, if sent by certified mail, return receipt requested; in each case to the following addresses or facsimile numbers and marked to the attention of the person (by name or 

8

title) designated below (or to such other address or facsimile number, or person as a party may designate in writing to the other parties):
	
			
	To the Company:
	 

	 
	CCA Industries, Inc. 
200 Murray Hill Parkway 
East Rutherford, New Jersey 07073 
Attention:  Stephen A. Heit, Executive Vice President & CFO 
Telephone: (201) 935-3232 
Fax:  (201) 935-4158

	To Holder:
	 

	 
	Capital Preservation Holdings, LLC
One Belmont Avenue
Suite 602
Bala Cynwyd, PA  19004
Attention:  Lance T. Funston
Telephone:  (610) 592-0049
Fax: (610) 592-0043 

10.    Antitakeover Provisions.  Company has taken all actions required to exempt this Warrant,  the Warrant Stock issuable pursuant to this Warrant, the parties hereto, and the other transactions contemplated hereby from any provisions of an anti-takeover nature contained in their organizational documents or the provisions of any federal or state “anti-takeover,” “fair price,” “moratorium,” “control share acquisition” or similar laws or regulations, including without limitation section 203 of the Delaware General Corporation Law (“Takeover Laws”).  Company shall not take any action that would cause any of the foregoing to be subject to requirements imposed by any Takeover Law, and Company shall take all necessary steps within its control to exempt (or ensure the continued exemption of) the foregoing from any applicable Takeover Law, as now or hereafter in effect.
11.    Choice of Law.  All issues and questions concerning the construction, validity, interpretation and enforceability of this Warrant shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.
12.    Jurisdiction.  The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state and federal courts located in the State of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Warrant (“Covered Matters”), (b) agree not to commence any suit, action or other proceeding arising out of or based upon any Covered Matters except in the state courts or federal courts located in the State of Delaware, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is 

9

improper or that this Warrant or the subject matter of any Covered Matter may not be enforced in or by such court
13.    Severability.  In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
14.    Successor and Assigns.   This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder. 
15.    No Third-Party Beneficiaries.   This Warrant is for the sole benefit of the Company and the Holder and their respective successors and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant. 
16.    Headings.   The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant. 
17.    Amendment and Modification.   Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. 
18.    Counterparts.   This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.
[Remainder of this page intentionally left blank; signature page follows]

10

IN WITNESS WHEREOF, the undersigned has duly executed this Warrant as of the Issuance Date.
CCA INDUSTRIES, INC., 
a Delaware corporation 
 
 
 
 
By:   /s/ Stanley Kreitman          
       Name:    Stanley Kreitman  
       Title:     Chairman of the Board

ACCEPTED AND AGREED:
CAPITAL PRESERVATION SOLUTIONS, LLC, 
a Delaware limited liability company
 
 
 
 
By:  /s/ Lance T. Funston          
       Name:  Lance T. Funston     
       Title:  Sole Member     

FORM OF EXERCISE NOTICE
[May only be executed by the registered holder hereof]
The undersigned hereby exercises the right to purchase _________ shares of common stock, par value $0.01 per share (“Common Stock”), of CCA Industries, Inc., evidenced by the within Warrant Certificate, and tenders herewith payment of the purchase price for such shares in full in the following manner:
		
	_____ 
	The undersigned elects to exercise the Warrant by means of a cash payment in accordance with the provisions of Section 2(b)(i) of the Warrant, and tenders herewith payment in full for the purchase price of the shares being purchased.

		
	_____ 
	The undersigned elects to exercise the Warrant by means of a “cashless” exercise in accordance with the provisions of Section 2(b)(ii) of the Warrant.

		
	___
	The undersigned elects to exercise the attached Warrant by means of both a cash payment and a “cashless” exercise in accordance with the provisions of Section 2(b)(iii) of the Warrant, and tenders herewith payment in full for that portion of the purchase price being paid in cash.

________________________________
(Name)

_________________                    ________________________________
(Date)    (Signature)EX 10.3- SeparationAgreement-Edell

EXHIBIT 10.3

[CCA INDUSTRIES, INC. LETTERHEAD]
September 5, 2014

Dear David:
This Letter Agreement sets forth the terms and conditions of your decision to voluntarily end your consulting arrangement pursuant to your Amended and Restated Employment Agreement with CCA Industries, Inc., dated as of December 1, 1993, as amended by the (i) Amendment to the Amended and Restated Employment Agreement dated December 1, 1993, dated as of December 31, 1998, (ii) Amended and Restated Employment Agreement dated as of June 1, 2001, and (iii) Amended and Restated Employment Agreement, dated as of October 16, 2002 (collectively, the “Employment Agreement”), as well as voluntarily end any relationship you have had with any of CCA Industries, Inc.’s affiliates or subsidiaries (collectively, the “Company”), and the parties’ agreement on matters relating to the end of your consulting arrangement and any relationship with the Company, and terminate the Employment Agreement and your Change of Control Agreement with the Company dated as of March 15, 2011 (the “Change of Control Agreement”), in each case, except as otherwise provided herein.  
Your consulting arrangement with the Company shall cease, and the Employment Agreement and the Change of Control Agreement shall terminate, effective as of the closing of that certain Stock Purchase Agreement by and between you and Capital Preservation Holdings, LLC, a Delaware limited liability company (“Buyer”), dated September 5, 2014 (the “Stock Purchase Agreement”), pursuant to which you have agreed to sell all of your shares of Class A Common Stock of the Company and 100,000 shares of Common Stock of the Company to Buyer (such closing date, the “Separation Date”).
1.General Terms of Voluntary Cessation of Relationship with the Company.
(a)    Effective on the Separation Date, your consulting arrangement with the Company and any other relationship you have had with the Company shall cease, and, except as otherwise provided herein, the Employment Agreement and the Change of Control Agreement shall terminate, and you shall not be eligible for any other fees, payments, compensation, wages or benefits except as set forth herein.  
(b)    You will be paid the gross amount of $404,583, payable over fifteen (15) months after the Separation Date in equal monthly installments not later than the the third day of each month (or, if such third day is a Saturday, a Sunday or a day on which banks are authorized or required to be closed by law in the State of New Jersey, the preceding business day) commencing 

David Edell
September 5, 2014
Page 2

on October 3, 2014 and ending on January 3, 2016, which amount represents all amounts due and owing to you for all services provided by you to the Company, including pursuant to the Employment Agreement, up to and including the Separation Date.
(c)    You will be reimbursed for any eligible expenses that have not yet been reimbursed pursuant to Section 5 of the Employment Agreement, upon presentation of appropriate receipts, in accordance with the Company’s practices.
(d)    Until December 31, 2015, the Company will continue to permit you to use the Company car which you were entitled to use immediately prior to the Separation Date and, during such time, the Company will continue to pay all lease payments associated with such car.
(e)    Until December 31, 2016, the Company will continue to pay directly to John Hancock Life Insurance Company (U.S.A.) all of the premium payments associated with your existing life insurance policies (Policy Nos. 59 100 248 and 59 100 040).
(f)    Effective as of the Separation Date you shall not be eligible for any other payments, fees, compensation or benefits of any kind from the Company.
(g)    You remain obligated to continue to comply with the post-consultancy covenants contained in the Employment Agreement, including, without limitation, those set forth in Section 9 of the Employment Agreement, which shall remain in full force and effect.
(h)    You remain obligated to continue to comply with the post-consultancy covenants contained in the Change of Control Agreement, including, without limitation, those set forth in Section 4 of the Change of Control Agreement, which shall remain in full force and effect.
(i)    Effective as of the Separation Date, you will resign as a member of the Board of Directors of the Company.
2.    Separation Payment; Release by the Company.  Provided that you execute this Letter Agreement and comply with your obligations hereunder, and in consideration for the General Release set forth in Paragraph 3 below, the Company shall provide you with the following:
(a)    Separation Payment.  The Company shall pay you the following (collectively, the “Separation Payment”): 
(i)    a lump sum payment equal to $500,000, payable on the Separation Date; and
(ii)    a lump sum payment equal to $100,000, payable on or before October 1, 2015.   

David Edell
September 5, 2014
Page 3

(b)    Release by the Company.  The Company and each of its divisions, affiliates, subsidiaries, parents, predecessors, successors and assigns hereby unconditionally, irrevocably and for all purposes releases and forever discharges you from any and all rights, claims and causes of action, suits, liabilities, obligations, debts, dues, sums of money, accounts, reckonings, bonds, bills, covenants, contracts, controversies, agreements, promises, damages, judgments, executions, claims and demands, in law or equity, known or unknown, that the Company has, had or may have against you from the beginning of time through the date of this Agreement (“Company Claims”), except for (a) any Company Claims relating to fraud, embezzlement, theft or criminal misconduct, (b) any Company Claims to interpret or to determine the scope, meaning, enforceability or effect of this Letter Agreement, (c) any Company Claims relating to a breach or violation of the terms or provisions of this Letter Agreement, (d) any Company Claims that arise after you have signed this Letter Agreement and (e) any breach of your fiduciary duties to the Company or its stockholders. 
(c)    Consideration and Value.  The parties acknowledge that the monies and benefits set forth in Sections 2(a) and 2(b) represent amounts and terms in addition to anything of value to which you are otherwise entitled and represent good, valuable, and sufficient consideration for the mutual promises and duties set forth in this Letter Agreement.
3.    Acknowledgment of Independent Contractor Status; General Release by You.  By signing this Letter Agreement, you hereby agree and confirm that your status with the Company since January 1, 2011 has been that of an independent contractor, not an employee. Notwithstanding your status as an independent contractor, you hereby provide the following comprehensive General Release:
(a)    In consideration of the Separation Payment and other benefits set forth herein in Paragraph 2, to which you agree you would not be entitled without executing this Letter Agreement, you release and forever discharge, to the maximum extent permitted by law, the Company and each of the other “Company Released Parties” as defined below, from any and all claims, causes of action, complaints, lawsuits or liabilities of any kind (collectively “Claims”) as described below which you, your heirs, agents, administrators or executors have or may have against the Company or any of the other Company Released Parties.
(b)    By agreeing to this General Release, you are waiving any and all Claims that can be waived, to the maximum extent permitted by law, which you have or may have against the Company or any of the other Company Released Parties arising out of or relating to any conduct, matter, event or omission existing or occurring before you sign this Agreement, and any monetary or other personal relief for such Claims, including but not limited to the following:  any Claims having anything to do with your provision of independent contractor/consulting services to the Company; any Claims having anything to do with your voluntary cessation of your consulting arrangement, including pursuant to the Employment Agreement and the Change of Control 

David Edell
September 5, 2014
Page 4

Agreement; any Claims related in any way to any other relationship you have had with the Company and the cessation of that arrangement; any Claims for unpaid or withheld fees, payments, wages, severance, benefits, incentive compensation, bonuses, commissions, stock,  stock options and/or other compensation or payments of any kind; any Claims related to or arising under the Employment Agreement, including any Claims that the Company improperly ended the Employment Agreement and/or any Claims that your rights under the Employment Agreement or the Change of Control Agreement were violated; any Claims for reimbursement of expenses of any kind; any Claims for attorneys’ fees or costs; any Claims under the Employee Retirement Income Security Act (“ERISA”); any Claims of discrimination and/or harassment based on age, sex, pregnancy, race, religion, color, creed, disability, handicap, failure to accommodate, citizenship,  marital status, national origin, ancestry, sexual orientation, gender identity, genetic information or any other factor protected by Federal, State or Local law as enacted or amended (such as the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq.,  Title VII of the Civil Rights Act of 1964, Section 1981 of the Civil Rights Act of 1866, the Americans with Disabilities Act, the Equal Pay Act, the Genetic Information Non-Discrimination Act, the New Jersey Law Against Discrimination) and any Claims for retaliation under any of the foregoing laws; any Claims regarding leaves of absence including, but not limited to, any Claims under the Family and Medical Leave Act; any Claims for violation of public policy; any whistleblower or retaliation Claims any whistleblower or retaliation Claims including but not limited to any Claims under the New Jersey Conscientious Employee Protection Act, N.J. Stat. Ann. § 34:19-3, et seq., including but not limited to claims for alleged “retaliatory action” pursuant to N.J. Stat. Ann. § 34:19-2e, or violations of N.J. Stat. Ann. § 34:19-3a or c; any Claims for emotional distress or pain and suffering; and/or any other statutory, regulatory, common law or other Claims of any kind, including, but not limited to, Claims for breach of contract, libel, slander, fraud, wrongful discharge, promissory estoppel, equitable estoppel, invasion of privacy and misrepresentation.
(c)    The term “Company Released Parties” includes:  the Company and any parent, subsidiary, related or affiliated companies of the Company, and each of their past and present employees, officers, directors, attorneys, owners, partners, insurers, funds, benefit plan fiduciaries and agents, and all of their respective successors and assigns.
(d)    It is important that you understand that this General Release includes all Claims known or unknown by you, those that you may have already asserted or raised as well as those that you have never asserted or raised.
(e)    Non-Released Claims.  Notwithstanding the foregoing, nothing in this Paragraph 3(e) shall:  (i) affect any rights you have to indemnification or Directors and Officers liability insurance (or similar coverage or policy) covering you during your consultancy with the Company, (ii) affect any rights you have with respect to any Claims that arise after you have signed this Agreement, or (iii) prohibit you from enforcing this Letter Agreement or making any Claim to 

David Edell
September 5, 2014
Page 5

interpret or to determine the scope, meaning, enforceability or effect of this Agreement.  The release set forth in this Paragraph 3(e) is subject to your Retained Rights set forth in Paragraph 4.
4.    Retained Rights.  Nothing in this Agreement is intended to nor shall be interpreted:  (a) to restrict or otherwise interfere with your obligation to testify truthfully in any forum; or (b) to restrict or otherwise interfere with your right and/or obligation to contact, cooperate with or provide information to any government agency or commission.  However, the release in Paragraph 3 does prevent you, to the maximum extent permitted by law, from obtaining any monetary or other personal relief for any of the claims you have released in Paragraph 3 with regard to any charge you may file or which may be filed on your behalf.  
5.    Restrictive Covenants.  As set forth above, regardless of whether you execute this Letter Agreement, you remain obligated to comply with the post-consultancy covenants contained in (a) the Employment Agreement, including, without limitation, those set forth in Section 9 thereof, and (b) the Change of Control Agreement, including, without limitation, those set forth in Section 4 thereof.   You acknowledge and agree that (i) Section 9 of the Employment Agreement survives the cessation of your consulting arrangement with the Company, shall remain in full force and effect and is not modified by this Letter Agreement and (ii) Section 4 of the Change of Control Agreement survives the cessation of your consulting arrangement with the Company, shall remain in full force and effect and is not modified by this Letter Agreement.  The parties hereto also each acknowledge and agree that your continued adherence to such covenants is a material inducement to the Company to provide you with the Separation Payment and benefits set forth in Paragraph 2 hereof.
6.    Return of Company Property.  You agree, to the extent you have not done so already, to return to the Company’s Chief Executive Officer, immediately, all property of the Company Released Parties in your possession, custody, or control, including, but not limited to, all originals and copies of documents and other materials containing or derived from any confidential information, credit cards, keys, telephone cards, car service cards and vouchers, computer software or hardware paid for by the Company Released Parties, identification cards, records, contact lists (excluding your personal contacts), and client lists and copies thereof, correspondence and copies of correspondence and other books or manuals issued by the Company Released Parties.  After giving effect to such return, you represent and warrant that you have returned all property of the Company Released Parties.
7.    Confidentiality of Letter Agreement.  You agree that the terms and conditions of this Letter Agreement are confidential and that you will not disclose the terms and conditions of this Letter Agreement to any third parties, provided that you may disclose the terms and conditions of this Letter Agreement (a) to your spouse, immediate family members, attorney, or accountant, if you instruct such persons not to disclose the terms and conditions of this Letter Agreement to any third party, and provided that if any person to whom you disclose information pursuant to this 

David Edell
September 5, 2014
Page 6

Paragraph 7 discloses, in whole or in part, such information, you shall be deemed to have breached this Letter Agreement, (b) as required by law, including any disclosure obligations under the Securities Exchange Act of 1934, as amended, (c) as may be necessary to enforce this Letter Agreement or to comply with its terms, or (d) in connection with any of your Retained Rights as set forth in Paragraph 4.  Notwithstanding the foregoing, you may disclose your continuing obligations under this Letter Agreement to potential and/or future employers.  The Company agrees that it will not disclose the terms and conditions of this Letter Agreement to any persons or entities outside of the Company except as necessary to carry out the business of the Company, as required by law, judicial or regulatory process or as may be necessary to enforce this Letter Agreement or to comply with its terms.
8.    Remedy for Breach.  You and the Company each acknowledge that the provisions of Paragraphs 4, 5, 6, 7 and 9 of this Letter Agreement (as applicable) are reasonable and necessary for the protection of the parties hereto.  The parties hereto further acknowledge that the each of the Company or you may be irreparably harmed if such covenants are not specifically enforced. Accordingly, the parties hereto each agree that, in addition to any other relief to which you or the Company may be entitled, including claims for damages, you or the Company (as applicable) shall be entitled to obtain injunctive relief (without the requirement of any bond) from a court of competent jurisdiction for the purpose of restraining the other party from an actual or threatened breach of such covenants.
9.    Non-Admission; Inadmissibility; Non-disparagement.  This Letter Agreement does not constitute an admission by the Company that any action it took with respect to you was wrongful, unlawful or in violation of any local, state or federal act, statute, or constitution, or susceptible of inflicting any damages or injury on you, and the Company specifically denies any such wrongdoing or violation.  This Letter Agreement is entered into solely to resolve all matters related to or arising out of your consulting arrangement with and the cessation thereof from the Company, and its execution and implementation may not be used as evidence, and shall not be admissible in a subsequent proceeding of any kind, except one alleging a breach of this Letter Agreement.
You agree that you will not at any time publish or communicate to any person or entity any Disparaging remarks (as defined herein), comments or statements concerning the Company Released Parties.
The Company agrees not to publish or communicate to any person or entity any Disparaging remarks, comments or statements concerning you.  For purposes of this Letter Agreement “Disparaging” remarks, comments, or statements are those that impugn the character, honesty, integrity or morality or business acumen or abilities in connection with any aspect or the operation of business of the individual or entity being disparaged but shall not include any truthful statements 

David Edell
September 5, 2014
Page 7

made to any regulator or judicial authority pursuant to a regulatory or judicial requirement.  This restriction is subject to and limited by your Retained Rights in Paragraph 4.
10.    Reformation and Severability.  It is the intent of the parties that the provisions of this Letter Agreement be enforced to the fullest extent permitted by law.  If any provision of this Letter Agreement shall be declared by a court of competent jurisdiction to be invalid, illegal or unenforceable as written, the parties agree that the court shall modify and reform such provision to permit enforcement to the greatest extent permitted by law.  In addition, if any provision of this Letter Agreement shall be declared invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions of this Letter Agreement shall in no way be affected or impaired thereby.
11.    Cooperation in Government Proceedings and Other Litigation.  You agree that you will cooperate with any reasonable request of the Company to participate in the preparation for, response to, prosecution and/or defense of any pending, actual or threatened governmental proceeding or other private or governmental proceeding involving the Company and/or its affiliates and subsidiaries, including, without limitation, litigation, arbitrations, investigations and administrative charges. The Company will reimburse you for all of your reasonable out-of-pocket expenses, including legal fees of an attorney of your choosing, incurred as a result of such cooperation.  In the event you receive a request, demand or inquiry, whether orally, in writing, electronically or otherwise, for information relating to any such proceeding or litigation, you must notify immediately the Company’s Chief Executive Officer by telephone and email.
12.    Reliance on Representations and Promises. The parties hereto each acknowledge and agree that they have each made certain material representations and promises in this Letter Agreement on which the other party has relied to both enter into this Letter Agreement and pay or receive (as applicable) the consideration set forth in Paragraph 2 of this Letter Agreement.  The parties hereto each acknowledge and agree that, in the event that the other party does not fully abide by all such representations and promises, then such aggrieved party, its affiliates, and/or any of the Company Released Parties or you may seek:  (i) injunctive and equitable relief to enforce such promises as set forth in this Letter Agreement; (ii) monetary relief for any and all harm that such party, its affiliates and/or the Company Released Parties (all of whom are either parties or intended third party beneficiaries of this Letter Agreement) or you may suffer due to your or the Company’s, as applicable, breach of the obligations under this Letter Agreement; and (iii) all other equitable and legal relief that may be available under the law.
13.    Miscellaneous.
(a)    You acknowledge that you are not otherwise entitled to receive the consideration provided for herein from the Company as set forth in Paragraph 2 of this Letter Agreement.

David Edell
September 5, 2014
Page 8

(b)    You further represent and warrant that, except as set forth herein, no promises or inducements for this Letter Agreement have been made, and you are entering into this Letter Agreement without reliance upon any statement or representation by any of the Company Released Parties or any other person.  You understand that as a result of entering into this Letter Agreement you will not have the right to assert and will have waived any Claims that the Company unlawfully terminated your consulting arrangement or violated any rights in connection with your consulting arrangement, the Employment Agreement or the Change of Control Agreement.
(c)    The Company hereby advises you to consult with an attorney prior to signing this Letter Agreement.
14.    Effective Date.  This Letter Agreement will be effective as of the Separation Date.
15.    Acknowledgment/Total Consideration.  You acknowledge and agree that, effective on the Separation Date, you shall not be eligible for any fees, payment wages, and/or compensation from the Company or Company-paid benefits (including but not limited to pursuant to the Employment Agreement or the Change of Control Agreement), except as expressly set forth in this Letter Agreement and that this Letter Agreement sets forth the total consideration to be paid to you by the Company and is in lieu of any and all payment for services and/or other consideration of any kind which at any time has been the subject of any prior discussion, representations, inducements or promises, oral or written, direct or indirect, contingent or otherwise. You also acknowledge and agree that you have been paid for all services provided by you to the Company and have received all other fees, payment wages, and/or compensation and/or benefits of any kind owed to you, including but not limited to pursuant to the Employment Agreement and the Change of Control Agreement, except for any payments owed to you pursuant to Paragraph 1, which shall be paid to you in accordance with this Letter Agreement.
16.    Entire Agreement.  This Letter Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof, and supersedes any and all prior agreements, understandings, discussion, representations, inducements or promises, oral or written, direct or indirect, contingent or otherwise between the parties arising out of or relating to the cessation of your consulting arrangement with the Company and the termination of the Employment Agreement and the Change of Control Agreement, except for your continuing obligations set forth in Paragraph 5.  This Letter Agreement may only be modified or amended by written agreement executed by the parties.
17.    Choice of Law and Venue.  This Letter Agreement shall be governed by the laws of the State of New Jersey, without giving effect to the principles of conflicts of law.  Any action to enforce this Letter Agreement shall be brought solely in the state or federal courts located in New Jersey.

David Edell
September 5, 2014
Page 9

18.    Representations.  You agree and represent that:
(a)    You have read carefully the terms of this Letter Agreement, including the General Release;
(b)    You have had an opportunity to and have been encouraged to review this Letter Agreement, including the General Release, with an attorney;
(c)    You understand the meaning and effect of the terms of this Letter Agreement, including the General Release;
(d)    You were given an adequate amount of time to determine whether you wished to sign this Letter Agreement, including the General Release;
(e)    Your decision to sign this Letter Agreement is of your own free and voluntary act without compulsion of any kind;
(f)    No promise or inducement not expressed in this Letter Agreement has been made to you;
(g)    You understand that you are waiving your Claims as set forth in Paragraph 3 above (subject to the limitations in Paragraph 4 above); and
(h)    You have adequate information to make a knowing and voluntary waiver of any and all Claims as set forth in Paragraph 3 above.
(i)    Other than the Employment Agreement and the Change of Control Agreement, neither you nor any of your affiliates (including any member of your immediate family) is a party to any contracts, agreements, instruments, commitments or other arrangements, whether written or oral, with the Company prior to the Separation Date.
19.    Headings.  The headings in this Letter Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning of terms contained herein.
20.    Counterparts.  This Letter Agreement may be executed in counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument.
21.    Successors and Assigns.  This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.
[Signatures follow on next page]

David Edell
September 5, 2014
Page 10

Please sign where indicated below and return this Letter Agreement to the Company as set forth above.
	
				
	Sincerely,
CCA INDUSTRIES, INC.

	By:
	/s/ Stephen A. Heit

	Name:
	Stephen A. Heit

	Title:
	Chief Financial Officer

	
			
	Agreed to and accepted by:
	 

	/s/ Ira Berman, as attorney-in fact for David Edell

	David Edell
	 

	Date:
	September 5, 2014

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]